BPIQ Blog

$XBI $141.20 +4.5% 📈 Covid Updates $VBIV +3% initiates enrollment in ph 1/2 study of prophylactic COVID-19 vaccine VBI-2902. source...

$XBI $134.93 -3% 📉 Covid Updates $CYDY -28% Announced mix data in critically ill COVID-19 patients receiving Leronlimab PRO 140. They...

$XBI $138.77 +2.47% 📈 Covid Updates $CYDY (%) Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital...

$XBI $135.43 -3.22% 📉 COVID Updates $APLS (+0.29%) Apellis will not pursue additional development of APL-9 for severe COVID-19 source...

$XBI $139.94 -4.71% 📉 Covid Updates $MNOV (-1.75%) Discontinued Covid-19 vaccine development. source Pipeline Updates $BTAI (-10.44%)...

$XBI $153.10 +2% 📈 Covid Updates $MRNA +8% (AH) Shipped variant-specific vaccine candidate, mRNA-1273.351 to NIH for clinical study....

$XBI $154.29 -3% 📉 Covid Updates $NVAX -12% Enrollment complete in pivotal ph 3 trial in US and Mexico. source Pipeline Updates $CYDY...

$XBI $159.07 +2% 📈 Pipeline Updates $DTIL +8% 3-year pre-clinical data in non-human primates shows durability and safety of ARCUS...

$XBI $160.72 +1% 📈 Covid Updates $RDHL +4% First patient dosed in ph 2/3 study of RHB-107. source Pipeline Updates $NKTR +13%...

$XBI $160.16 -3% 📉 Covid Updates $MRNA -3% Provides US vaccine supply update. MRNA has supplied 45.4 million doses of Moderna COVID-19...

$XBI $168.01 -2% 📉 PIPELINE: $PLX -11% Phase 3 data from BRIDGE trial of pegunigalsidase alfa (PRX–102) treating Fabry Disease. source...

$XBI $171.86 -1% 📉 PIPELINE: $HTBX +50% Positive interim survival data from ongoing HS-110 ph 2 NSCLC trial. source $RMTI +30%...

$XBI $173.99 +4% 📈 COVID: $EIGR +12% Phase 2 covid data published in Lancet Respiratory Medicine journal. source PIPELINE: SRNE +18%...

$XBI $166.78 +2% 📈 PIPELINE: $TGTX +12% UKINIQ FDA approval for adult patients with relapsed or refractory marginal zone lymphoma after...

$XBI $162.77 +1% COVID: $DVAX +2% Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine...

Get BPIQ Pro and gain access to our database of over ~300 companies and ~1,200 drug assets. Featuring a fully searchable catalyst...

$XBI $163.24 +2% 📈 PIPELINE: $VYGR +6% $NBIX terminated collaboration $SAVA +141% Positive interim data $DRRX +18% FDA approval of...

$XBI $159.62 +4.41% 📈 COVID: $AMPE +15% - AMPIO ANNOUNCES EARLY POSITIVE DATA IN PHASE 1 TRIAL OF INHALED AMPION IN COVID-19 RESPIRATORY...

$XBI $152.88 (+0.82%) 📈 COVID: $CYDY (+8.82%) - Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate Special...

$XBI $151.64 (-0.43%) COVID: $NVAX (+2.16%) - Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial $RDHL (+1.38%) -...